Protara Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
TARA
CUSIP
74365U107
Type
Equity
Class
COM STK
Num filings
83
Total reported value, excl. options
$90.1 M
Manager Report Date Value ($000) Shares Option Type